Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential

Abstract The global increase in human life expectancy, coupled with an unprecedented rise in the prevalence of obesity, has led to a growing clinical and socioeconomic burden of heart failure with preserved ejection fraction (HFpEF). Mechanistically, the molecular and cellular hallmarks of aging are...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Fuerlinger, Alina Stockner, Simon Sedej, Mahmoud Abdellatif
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-024-02566-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595076688117760
author Alexander Fuerlinger
Alina Stockner
Simon Sedej
Mahmoud Abdellatif
author_facet Alexander Fuerlinger
Alina Stockner
Simon Sedej
Mahmoud Abdellatif
author_sort Alexander Fuerlinger
collection DOAJ
description Abstract The global increase in human life expectancy, coupled with an unprecedented rise in the prevalence of obesity, has led to a growing clinical and socioeconomic burden of heart failure with preserved ejection fraction (HFpEF). Mechanistically, the molecular and cellular hallmarks of aging are omnipresent in HFpEF and are further exacerbated by obesity and associated metabolic diseases. Conversely, weight loss strategies, particularly caloric restriction, have shown promise in improving health status in patients with HFpEF and are considered the gold standard for promoting longevity and healthspan (disease-free lifetime) in model organisms. In this review, we implicate fundamental mechanisms of aging in driving HFpEF and elucidate how caloric restriction mitigates the disease progression. Furthermore, we discuss the potential for pharmacologically mimicking the beneficial effects of caloric restriction in HFpEF using clinically approved and emerging caloric restriction mimetics. We surmise that these compounds could offer novel therapeutic avenues for HFpEF and alleviate the challenges associated with the implementation of caloric restriction and other lifestyle modifications to reduce the burden of HFpEF at a population level.
format Article
id doaj-art-d60bc8ee86ee4461b54b86f268f84d4f
institution Kabale University
issn 1475-2840
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj-art-d60bc8ee86ee4461b54b86f268f84d4f2025-01-19T12:09:04ZengBMCCardiovascular Diabetology1475-28402025-01-0124111710.1186/s12933-024-02566-8Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potentialAlexander Fuerlinger0Alina Stockner1Simon Sedej2Mahmoud Abdellatif3Department of Cardiology, Medical University of GrazDepartment of Cardiology, Medical University of GrazDepartment of Cardiology, Medical University of GrazDepartment of Cardiology, Medical University of GrazAbstract The global increase in human life expectancy, coupled with an unprecedented rise in the prevalence of obesity, has led to a growing clinical and socioeconomic burden of heart failure with preserved ejection fraction (HFpEF). Mechanistically, the molecular and cellular hallmarks of aging are omnipresent in HFpEF and are further exacerbated by obesity and associated metabolic diseases. Conversely, weight loss strategies, particularly caloric restriction, have shown promise in improving health status in patients with HFpEF and are considered the gold standard for promoting longevity and healthspan (disease-free lifetime) in model organisms. In this review, we implicate fundamental mechanisms of aging in driving HFpEF and elucidate how caloric restriction mitigates the disease progression. Furthermore, we discuss the potential for pharmacologically mimicking the beneficial effects of caloric restriction in HFpEF using clinically approved and emerging caloric restriction mimetics. We surmise that these compounds could offer novel therapeutic avenues for HFpEF and alleviate the challenges associated with the implementation of caloric restriction and other lifestyle modifications to reduce the burden of HFpEF at a population level.https://doi.org/10.1186/s12933-024-02566-8AgingHFpEFObesityFastingCaloric restriction mimeticsSGLT2
spellingShingle Alexander Fuerlinger
Alina Stockner
Simon Sedej
Mahmoud Abdellatif
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
Cardiovascular Diabetology
Aging
HFpEF
Obesity
Fasting
Caloric restriction mimetics
SGLT2
title Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
title_full Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
title_fullStr Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
title_full_unstemmed Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
title_short Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
title_sort caloric restriction and its mimetics in heart failure with preserved ejection fraction mechanisms and therapeutic potential
topic Aging
HFpEF
Obesity
Fasting
Caloric restriction mimetics
SGLT2
url https://doi.org/10.1186/s12933-024-02566-8
work_keys_str_mv AT alexanderfuerlinger caloricrestrictionanditsmimeticsinheartfailurewithpreservedejectionfractionmechanismsandtherapeuticpotential
AT alinastockner caloricrestrictionanditsmimeticsinheartfailurewithpreservedejectionfractionmechanismsandtherapeuticpotential
AT simonsedej caloricrestrictionanditsmimeticsinheartfailurewithpreservedejectionfractionmechanismsandtherapeuticpotential
AT mahmoudabdellatif caloricrestrictionanditsmimeticsinheartfailurewithpreservedejectionfractionmechanismsandtherapeuticpotential